Quay lại
Giá Akeso Inc (AKESF)
Biểu đồ giá cổ phiếu AKESF
AKESF Thu nhập
Akeso Inc
$15.47
-0.19%
$-0.02
Khi đóng cửa: Jan 16, 16:00:00 GMT-5
$15.55
0.51%
$0.08
Phiên sau giờ: Jan 16, 20:00:00 GMT-5
Thống kê chính
Giá đóng cửa trước
$15.5
Giá mở cửa
$15.53
Phạm vi ngày
$15.47 - $16.1
Phạm vi 52 tuần
$6.81 - $23.15
Khối lượng
--
Khối lượng trung bình
1.1K
EPS (TTM)
-0.14
Tỷ suất cổ tức
--
Vốn hóa thị trường
$14.3B
AKESF là gì?
Akeso, Inc. Is an investment company, which engages in the research and development, production, and sale of biopharmaceuticals products. The company is headquartered in Zhongshan, Guangdong and currently employs 3,529 full-time employees. The company went IPO on 2020-04-24. The Company’s programs covering the therapeutic areas of oncology, autoimmune and metabolic diseases. The firm's products mainly include cadonilimab (PD-1/CTLA-4), ivonescimab (PD-1/VEGF), Ligufalimab (AK117, CD47), Pulocimab (AK109, VEGFR-2), ANNIKO (penpulimab, PD-1), and tagitanlimab (PD-L1) used in oncology fields as well as ebronucimab (PCSK9), ebdarokimab (IL-12/IL-23), and Gumokimab (AK111, IL-17) used in metabolic and autoimmune therapeutic fields.
Đặc điểm
Chiến lược giao dịch
Tài nguyên
© 2025 Finture Development Limited. All rights reserved